Lung Cancer News
International patient-driven ROS1+ research initiative
The Bonnie J. Adario Lung Cancer Foundation (ALCF) is coordinating an international, patient-driven research project for ROS1+ cancer of all types. An initial survey has been designed in collaboration with experts at Stanford University to collect baseline data for any patients with ROS1+ tumours. This initiative and the ALCF are an excellent mechanism through which patients with this relatively rare type of disease can find support from other patients. Download the flyer for more information. Please circulate this among your networks and keep it in mind for any patients you know with this particular mutation.
Free IASLC membership for patients/survivors
In its July newsletter IASLC announced free membership for patients and survivors of any thoracic malignancy. Patients and survivors can renew this non-voting membership annually. Except for voting, this new membership category provides all Allied Health Professional member benefits and includes online access to the Journal of Thoracic Oncology, member meeting discounts, eligibility to apply for travel awards, and eligibility to serve on Committees.
Molecular testing guideline for EGFR and ALK TKIs – comments open on draft recommendations
The College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC) and Association for Molecular Pathology (AMP) are inviting comment on the draft recommendations for revising the Molecular Testing Guideline for lung cancer patients for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors. More information is available here.